Mónica Perona
A5033491685- Helicobacter pylori-related gastroenterology studies
- Gastroesophageal reflux and treatments
- Oral and gingival health research
- Eosinophilic Esophagitis
- Gastrointestinal motility and disorders
- Gastric Cancer Management and Outcomes
- Veterinary medicine and infectious diseases
- Child Nutrition and Feeding Issues
- Drug-Induced Adverse Reactions
- Oral Health Pathology and Treatment
- Immunodeficiency and Autoimmune Disorders
- Microscopic Colitis
- Celiac Disease Research and Management
- Aging, Health, and Disability
- Eosinophilic Disorders and Syndromes
- Oral and Maxillofacial Pathology
- Infant Health and Development
- Antifungal resistance and susceptibility
- Effects of Radiation Exposure
- Metabolism and Genetic Disorders
- Radiopharmaceutical Chemistry and Applications
- Nosocomial Infections in ICU
- Stress and Burnout Research
- Pneumonia and Respiratory Infections
- Neuroendocrine Tumor Research Advances
Hospital Quirónsalud Barcelona
2014-2024
Hospital Quirón Teknon
2004-2009
Ospedale Sant'Anna
1993
INTRODUCTION: The safety of Helicobacter pylori eradication treatments and to what extent adverse events (AEs) influence therapeutic compliance in clinical practice are hardly known. Our aim was assess the frequency, type, intensity, duration AEs, their impact on compliance, for most frequently used “European Registry management.” METHODS: Systematic prospective noninterventional registry European gastroenterologists (27 countries, 300 investigators) management H. infection routine practice....
OBJECTIVES: Rising trends in eosinophilic esophagitis (EoE) have been repeatedly linked to decliningHelicobacter pylori (H. pylori)infection, mostly retrospective studies. We aimed prospectively evaluate this inverse association. METHODS: Prospective case-control study conducted 23 centers. Children and adults naïve eradication therapy forH. pyloriwere included. Cases were EoE patients, whereas controls defined by esophageal symptoms <5 eos/HPF on biopsies.H. pyloristatus was diagnosed...
There has been resurgence in the use of bismuth quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) for treating Helicobacter pylori infection thanks to a three-in-one single-capsule formulation.To evaluate effectiveness safety therapy.Data were collected multicentre, prospective registry clinical practice gastroenterologists on management H. infection, where patients registered at Asociación Española de Gastroenterologia REDCap database an electronic case...
Objective. Functional gastrointestinal disorders (FGID) may appear after acute gastroenteritis. The aim of this study was to evaluate the possible mechanisms (inflammation, visceral hypersensitivity, psychological and immunogenetic factors) related development postinfectious (PI) FGID 3 years a Salmonella outbreak. Material andmethods. Biopsies antrum, right- left colon from 16 PI-FGID patients, 8 PI control 18 healthy controls (H-controls) were processed for immunohistochemistry, cytokines,...
Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) often prescribed as the first option, although more recently use quadruple therapy bismuth (B), tetracycline (T), M has been recommended.To evaluate efficacy safety first-line rescue treatments "European Registry H management" (Hp-EuReg).A systematic prospective registry clinical practice European...
Abstract Background Management of Helicobacter pylori ( H. ) infection requires co‐treatment with proton pump inhibitors (PPIs) and the use antibiotics to achieve successful eradication. Aim To evaluate role dosage PPIs duration therapy in effectiveness eradication treatments based on ‘European Registry management’ (Hp‐EuReg). Methods Hp‐EuReg is a multicentre, prospective, non‐interventionist, international registry routine clinical practice management by European gastroenterologists. All...
Abstract Background Different bismuth quadruple therapies containing proton‐pump inhibitors, salts, metronidazole, and a tetracycline have been recommended as third‐line Helicobacter pylori eradication treatment after failure with clarithromycin levofloxacin. Aim To evaluate the efficacy safety of treatments bismuth, either or doxycycline. Methods Sub‐study Spanish data “European Registry on H Management” (Hp‐EuReg), international multicenter prospective non‐interventional routine clinical...
The management of Helicobacter pylori infection has to rely on previous local effectiveness due the geographical variability antibiotic resistance. aim this study was evaluate first and second-line H. treatment in Spain, where empirical prescription is recommended. A multicentre prospective non-interventional registry clinical practice European gastroenterologists concerning (Hp-EuReg) developed, including patients from 2013 until June 2019. Effectiveness evaluated descriptively through a...
ABSTRACT Background The influence of indications for Helicobacter pylori investigation on prescriptions and effectiveness is unknown. aim the study was to assess impact H. prescriptions, effectiveness, compliance, tolerance. Methods International, prospective, non‐interventional registry management infection by European gastroenterologists (Hp‐EuReg). Treatment‐näive patients registered from 2013 2023 at e‐CRF AEG‐REDCap were analyzed. assessed modified intention‐to‐treat analysis. Results...
The recommended schedule for single capsule bismuth quadruple therapy (scBQT, Pylera) includes a proton pump inhibitor (PPI) two times day and three scBQT capsules four day. Four treatments are inconvenient reduce adherence. In contrast, adherence improves with schedules. clinical practice, many gastroenterologists use However, the effectiveness safety of this latter approach remain uncertain.To assess administered in patients included European Registry on Helicobacter pylori Management...
Anabolic steroids extracted from bovine serum by means of organic solvents or solid-phase extraction techniques with C18 cartridges are not suitable for quantitative analysis gas chromatography—mass spectrometry (GC—MS); therefore, they were Extrelut columns (Merck; Germany), eluted diethyl ether, and purified a technique using amino (NH2) columns. The resulting clean extract was treated heptafluorobutyric anhydride (HFBA); this formed derivative GC—MS analysis. Using selected ion monitoring...